Magnetic resonance imaging with liver-specific contrast agent in primary amyloidosis and intrahepatic cholestasis

J. M. Møller*, E. Santoni-Rugiu, E. Chabanova, V. Løgager, A. B. Hansen, H. S. Thomsen

*Corresponding author for this work
7 Citations (Scopus)

Abstract

Magnetic resonance imaging (MRI) findings in hepatic amyloidosis are not well defined. Here, we report on a patient with renal failure caused by primary amyloidosis (AL type) who developed jaundice. Ultrasound and computed tomography were normal except for some ascites. MRI with oral manganese-containing contrast agent revealed several focal areas without contrast uptake in the hepatocytes and no bile secretion after 8 hours. No extrahepatic bile obstructions were found. Liver biopsy showed severe intraportal, vascular, and parenchymal amyloidosis causing severe cholestasis and atrophy of hepatocytes.

Original languageEnglish
JournalActa Radiologica
Volume48
Issue number2
Pages (from-to)145-149
Number of pages5
ISSN0284-1851
DOIs
Publication statusPublished - 16 Mar 2007

Keywords

  • Abdomen
  • Bile duct
  • Liver
  • MR imaging
  • Oral contrast agent

Fingerprint

Dive into the research topics of 'Magnetic resonance imaging with liver-specific contrast agent in primary amyloidosis and intrahepatic cholestasis'. Together they form a unique fingerprint.

Cite this